Page last updated: 2024-10-27

gabexate and Hepatitis

gabexate has been researched along with Hepatitis in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Hepatitis: INFLAMMATION of the LIVER.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yasunaga, M1
Mori, K1
Yamashita, S1
Okita, K1

Other Studies

1 other study available for gabexate and Hepatitis

ArticleYear
[Clinical trial of protease inhibitor in the treatment of fulminant hepatitis].
    Nihon rinsho. Japanese journal of clinical medicine, 1991, Volume: 49, Issue:9

    Topics: Animals; Antithrombin III; Disseminated Intravascular Coagulation; Gabexate; Hepatitis; Humans; Prot

1991